ADVANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PURPOSES

Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sector of biopharmaceuticals, featuring promising improvements across many health care and industrial applications. With its structural similarity to In a natural way derived human serum albumin, OsrHSA supplies a safer, more reputable option for therapeutic use,